In prostate tumors and in prostate cancer metastasis to bone, TGFβ and/or BMP was shown to promote EndMT resulting in aberrant differentiation of tumor -associated ECs into cells with features of bone [60, 358]. This evidence concerns the gene TGFB1 and neoplasm.